Collider, a self-proclaimed beer that delivers a first-of-its-kind mood-boosting buzz while maintaining top taste
The beer is made using special yeast strains, malt profile alteration and temperature control methods that allow only 0.5% of alcohol
Collider's unique offering - the first non-alcoholic beer in the world to contain both adaptogens and functional mushrooms
Collider's unique proposition is resonating well with customers with excellent reviews and 85% of them said they'd buy the beer again
Collider's key ingredients include Ashwagandha, L-theanine and Lion’s Mane, which are all found to be effective in promoting cognitive ability improvement
Non-alcoholic beers are gaining massive popularity in the market with consumers looking for more alcohol-free options
The beverage category has historically held steady during recessions with many categories outperforming other personal consumption expenditures
Collider is well-positioned to attract potential acquirers in the future with its unique product positioning and macro market tailwinds
dmg media's vast consumer reach can benefit Collider greatly, given the brand's wide appeal to consumers
The early-stage investment from dmg ventures will help Harry Cooke take on the giant opportunity in front of Collider